|
|
|||||
|
|
|
|
|
|
|
|
|
|||||
University of
LIST OF PUBLICATIONS
2007
Bradburn MJ, Deeks JJ,
2006
Apter AJ, Kinman JL, Bilker WB, Herlim M, Margolis DJ, Lautenbach E, Hennessy S, Strom BL. Is there cross-reactivity between penicillins and cephalosporins? Investigation using a large electronic medical record database. American Journal of Medicine April 2006; 119(4):354.e11-354.e20.
Sauer WH, Cappola AR, Berlin JA, Kimmel SE. Insulin sensitizing pharmacotherapy for prevention of myocardial infarction in patients with diabetes mellitus. American Journal of Cardiology 2006 Mar 1; 97(5):651-654.
Graham J, Bennett I, Holmes W, Gross R Medication beliefs as mediators of the health literacy-antiretroviral adherence relationship in HIV-infected individuals. AIDS and Behavior 2006 Oct 20; [Epub ahead of print]
Gross R, Yip B, Lo Re V III, Wood E, Alexander CS, Harrigan PR, Bangsberg DR, Montaner JSG, Hogg RS. A simple dynamic measure of antiretroviral adherence predicted failure to maintain HIV suppression. Journal of Infectious Diseases 2006; 194:1108-1114.
Hennessy S, Leonard C, Wang Y, Kimmel SE, Townsend RR, Wasserstein AG, Ten Have TR, Bilker WB. Effectiveness of a two-part educational intervention to improve hypertension control: a cluster-randomized trial. Pharmacotherapy 2006 Sep; 26(9):1342-1347.
Albrecht SJ, Fishman NO, Kitchen J, Nachamkin I, Bilker WB, Hoegg C, Samel C, Barbagallo S, Arentzen J, Lautenbach E. Reemergence of gram-negative health care-associated bloodstream infections. Archives of Internal Medicine 2006 Jun 26; 166(12):1289-1294.
Lautenbach E, Fishman NO, Metlay JP, Mao X, Bilker WB, Tolomeo P, Nachamkin I. Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: Results from a large hospital-based surveillance initiative. Journal of Infectious Diseases 2006; 194:79-85.
Lautenbach E, Tolomeo P, Mao X,
Fishman NO, Metlay JP, Bilker WB, Nachamkin I. Duration of outpatient fecal
colonization due to Escherichia coli isolates with
decreased susceptibility to fluoroquinolones: longitudinal study of patients
recently discharged from the hospital. Antimicrobial Agents and Chemotherapy 2006 Nov; 50(11):3939-3943.
M’ikanatha NM, Rohn DD, Robertson C, Tan GT, Holmes JH, Kunselman AR, Polachek C, Lautenbach E. Use of the internet to enhance infectious disease surveillance and outbreak investigation. Biosecurity and Bioterrorism 2006; 4(3):293-300.
Mizuta
M,
Lipworth
AD, Hyle EP, Fishman NO, Nachamkin I, Bilker WB, Marr AM, Larosa LA, Kasbekar
N, Lautenbach E. Limiting the emergence of extended-spectrum
B-lactamase-producing Enterobacteriaceae: influence of patient population
characteristics on the response to antimicrobial formulary interventions. Infection
Control and Hospital Epidemiology 2006 March; 27(3):279-286.
MacAdam
H, Zaoutis TE, Gasink LB, Bilker WB, Lautenbach
E. Investigating the association
between antibiotic use and antibiotic resistance: impact of different methods
of categorising prior antibiotic use. International Journal of Antimicrobial
Agents 2006 Oct; 28(4):325-332.
Hass DJ, Lewis JD. Quality of manufacturer provided information on safety and efficacy claims for dietary supplements for colonic health. Pharmacoepidemiology and Drug Safety 2006 Aug; 15(8):578-586
Gupta G, Lautenbach E, Lewis JD. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease. Clinical Gastroenterology and Hepatology 2006 Dec; 4(12): 1483-1490.
Linkin DR, Paris S, Fishman NO, Metlay JP, Lautenbach E. Inaccurate communication in telephone calls to an antimicrobial stewardship program. Infection Control and Hospital Epidemiology 2006; 27:688-694.
Lo Re III V, Frank I, Gross R, Dockter J, Linnen JM, Giachetti C,
Tebas P, Stern J, Synnestvedt M,
Lo Re III V, Kostman JR, Gross R, Reddy KR, Mounzer K, Zemel BS Rennert H, Stieritz DD, Putt M, Frank I, Strom BL. Incidence and risk factors for weight loss during dual HIV/Hepatitis C virus therapy.
J Acquir Immune Defic Syndr 2006 Dec 14; [epub ahead of print]
Bowe WP, Filip JC, DiRienzo JM, Volgina A, Margolis DJ. Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. Journal of Drugs in Dermatology Oct 2006; 5: 868-870.
Metlay JP, Fishman NO, Joffe M, Edelstein PH. Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults. Vaccine 2006 Jan 23; 24(4):468-475. Epub 2005 Aug 15.
Walker AM, Langleben D, Korelitz JJ, Rich S, Rubin LJ, Strom BL. et al. Temporal trends and drug exposures in pulmonary hypertension: an American experience. American Heart Journal 2006 Sep; 152(3):521-526.
2005
Berlin JA, Ghersi D. Preventing publication bias: registries and
prospective meta-analysis. Chapter 3 In Rothstein H, Borenstein M, Sutton AJ
(eds). Publication Bias in Meta-Analysis: Prevention, Assessment and
Adjustments.
Mikuls TR, Farrar JT, Bilker W, Fernandes S, Schumacher HR Jr, Saag KG.
Gout epidemiology: results from the
Gross R, Zhang Y, Grossberg R. Medication refill logistics and refill
adherence in HIV. Pharmacoepidemiology Drug Safety 2005; 14:789-793.
Hyle EP, Lipworth AD, Zaoutis T, Nachamkin I, Fishman NO, Bilker WB, Mao X, Lautenbach
E. Risk factors for increasing multidrug resistance among extended-spectrum
beta-lacW:\CERTpublications.htmltamase-producing Escherichia coli and
Klebsiella species. Clinical Infectious Diseases 2005; 40:1317-1324.
Hyle EP, Lipworth AD, Zaoutis T, Nachamkin I, Bilker WB, Lautenbach E. Impact
of inadequate initial antimicrobial therapy on mortality in infections due to
extended-spectrum beta-lactamase-producing-enterobacteriaceae: variability by
site of infection. Archives of Internal Medicine 2005 Jun 27;
165(12):1375-1380.
Kersun LS, Propert KJ, Lautenbach E, Bunin N, DeMichele A. Early
bacteremia in pediatric hematopoietic stem cell transplant patients on oral
antibiotic prophylaxis. Pediatric Blood and Cancer 2005; 45:162-169.
Lautenbach E, Metlay JP, Bilker WB, Edelstein PH, Fishman NO.
Association between fluoroquinolone resistance and mortality in Escherichia
coli and Klebsiella pneumoniae infections: the role of inadequate empirical
antimicrobial therapy. Clinical Infectious Diseases 2005 Oct 1;
41(7):923-929.
Lautenbach E, Harris AD, Perencevich EN, Nachamkin I, Tolomeo P, Metlay
JP. Test characteristics of perirectal and rectal swab compared to stool sample
for detection of fluoroquinolone-resistant Escherichia coli in the
gastrointestinal tract. Antimicrobial Agents and Chemotherapy 2005; 49
(2):798-800.
Barton TD, Fishman NO, Weiner MG, LaRosa LA, Lautenbach E. High rate of
coadministration of di- or tri-valent cation-containing compounds with oral
fluoroquinolones: risk factors and potential implications. Infection Control
and Hospital Epidemiology 2005 Jan; 26(1):93-99.
Viray M, Linkin D, Maslow JN, Stieritz DD, Carson LS, Bilker WB, Lautenbach
E. Longitudinal trends in antimicrobial susceptibilities across
long-term-care facilities: emergence of fluoroquinolone resistance. Infection
Control and Hospital Epidemiology 2005 Jan; 26(1):56-62.
Mikanatha N, Julian KG, Kunselman AR, Aber R, Rankin JT, Lautenbach E.
Patients' request for and emergency physicians' prescription of antimicrobial
prophylaxis for anthrax during the 2001 bioterrorism-related outbreak. BMC
Public Health 2005 Jan 5; 5(1):2.
Aberra FN, Brensinger CM, Bilker WB,
Lichtenstein GR, Lewis JD. Antibiotic use and the risk for flares
of inflammatory bowel disease. Clinical Gastroenterology and Hepatology 2005
May; 3(5):459-465.
Lewis JD, Bilker WB, Weinstein RB,
Strom BL. The relationship between time
since registration and measured incidence rates in the General Practice
Research Database. Pharmacoepidemiology and Drug Safety 2005;14 (7): 443-451.
Levy RM,
Margolis DJ, Bowe W, Hoffstad O,
Aspinall,
SL,
Metlay JP, Cohen A, Polsky D, Hennessy
S. Medication safety among older
adults: home based practice patterns. Journal
of the American Geriatrics Society 2005 Jun; 53(6):976-982.
Long
CB, Shah SS, Lautenbach E, Coffin SE, Tabbutt S, Gaynor JW, Bell LM.
Postoperative mediastinitis in children: epidemiology, microbiology, and risk
factors for Gram-negative pathogens. Pediatric Infectious Disease Journal
2005 Apr; 24(4):315-319.
Shah SS, Lautenbach E, Long CB, Tabbut S, Gaynor JW, Bilker WB, Bell LM.
Staphylococcus aureus as a risk factor for bloodstream infection in children
with post-operative mediastinitis. The Pediatric Infectious Disease Journal
2005 Sept; 24(9):834-837.
Coogan PF, Palmer JR, Strom BL, Rosenberg L. Use of selective serotonin reuptake inhibitors and the risk of breast cancer. American Journal of Epidemiology 2005; 162:835-838.
Zhang Y, Coogan PF, Palmer JR, Strom BL, Rosenberg L. Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the case-control surveillance study revisited. American Journal of Epidemiology 2005; 162:165-170.
Coogan PF, Zhang Y, Palmer JR, Strom BL, Rosenberg L. Cimetidine and other Histamine2-receptor antagonist use in relation to risk of breast cancer. Cancer Epidemiology, Biomarkers & Prevention 2005; 14:1012-15.
Zaoutis
TE, Goyal M, Chu JM, Susan E. Coffin SE, Bell LM, Nachamkin I, McGowan KL,
Bilker WB, Lautenbach E. Risk factors for and outcomes of bloodstream infection
caused by extended-spectrum beta-lactamase-producing Escherichia coli and
Klebsiella species in children. Pediatrics 2005 Apr; 115(4):942-949.
2004
Apter AJ, Kinman JL, Bilker WB, Herlim M, Margolis DJ, Lautenbach E,
Hennessy S, Strom BL. Represcription of penicillin after allergic-like events. Journal
of Allergy and Clinical Immunology 2004; 113:764-770.
Schmid CH, Stark PC, Berlin JA, Landais P, Lau J. Meta-regression
frequently finds associations between heterogeneous treatment effects and
study-level, but not patient-level factors. Journal of Clinical Epidemiology
2004; 57:683-697.
Berlin JA, Ghersi D. Prospective meta-analysis in dentistry. Journal
of Evidence-Based Dental Practice 2004; 4:59-64.
Lo Re III V, Gasink L, Kostman JR, Leonard D, Gross R. Natural history
of low-level HIV viremia on antiretroviral therapy. AIDS Patient Care
and STDs 2004; 18:436-442.
Grossberg R, Zhang Y, Gross R. A time-to-prescription-refill measure of
antiretroviral adherence predicted changes in viral load in HIV. Journal of
Clinical Epidemiology 2004; 57(10):1107-1110.
Hennessy S, Bilker W, Knauss J, Kimmel S, Margolis D, Morrison M, Reynolds R, Glasser D, Strom B. Comparative cardiac safety of low-dose thioridazine and low-dose haloperidol. British Journal of Clinical Pharmacology 2004; 58: 81-87. Available from: http://www.cceb.med.upenn.edu/hennessy/cv.html.
Mikanatha NM, Welliver DP, Rohn DD, Julian KG, Lautenbach E. Use of the web by state and territorial health departments to promote infectious disease reporting [research letter]. Journal of the American Medical Association 2004; 291 (9):1069-1070.
Lewis JD, Aberra FN, Lichtenstein GR, Bilker WB, Brensinger C, Strom BL. Seasonal variation in flares of inflammatory bowel disease. Gastroenterology 2004; 126(3):665-673.
Mikuls TR, MacLean CH, Olivieri J, Patino F, Allison JJ, Farrar J,
Bilker WB, Saag KG. Quality of care indicators for gout management. Arthritis
and Rheumatism 2004 March; 50(3):937-943.
Lautenbach E, Strom BL, W:\CERTpublications.htmlNachamkin I, Bilker WB,
Marr AM, Larosa LA, Fishman NO. Longitudinal trends in fluoroquinolone
resistance among enterobacteriaceae isolates from inpatients and outpatients,
1989-2000: differences in the emergence and epidemiology of resistance across
organisms. Clinical Infectious Diseases 2004; 38:655-662.
Lautenbach E, Gould CV, Larosa LA, Marr AM, Nachamkin I, Bilker WB,
Fishman NO. Emergence of resistance to chloramphenicol among
vancomycin-resistant enterococcal (VRE) bloodstream isolates. International
Journal of Antimicrobial Agents 2004; 23:200-203.
Gould CV, Fishman NO, Nachamkin I, Lautenbach E. Chloramphenicol
resistance in vancomycin-resistant enterococcal bacteremia: impact of prior
fluoroquinolone use? Infection Control and Hospital Epidemiology 2004;
25:138-145.
Linkin DR, Fishman NO, Patel JB, Merrill JD, Lautenbach E. Risk factors
for extended-spectrum beta-lactamase producing enterobacteriaceae in a neonatal
intensive care unit. Infection Control and Hospital Epidemiology 2004;
25:781-783.
Metlay JP, Branas CB, Fishman NO. Hospital- reported pneumococcal
susceptibility to penicillin. Emerging Infectious Diseases 2004;
10(1):54-59.
Papasavvas E, Kostman JR, Mounzer K, Grant RM, Gross R, Gallo C, Azzoni L, Foulkes A, Thiel B, Pistilli M, Mackiewicz A, Shull J, Montaner LJ. Randomized, controlled trial of therapy interruption in chronic HIV-1 infection. PLoS Medicine 2004 Dec; 1(3):e64.
Strom BL, Schinnar R. Participants and refusers in a telephone interview about hormone replacement therapy were equally likely to be taking it. Journal of Clinical Epidemiology 2004; 57:624-626.
2003
Everett WW, Coffin SE, Zaoutis T,
Halpern SD. Evaluating preference effects in partially unblinded, randomized clinical trials. Journal of Clinical Epidemiology 2003; 56:109-115.
Hennessy
S, Bilker WB, Weber A, Zhou L, Brensinger C, Wang Y, Strom BL.
Retrospective drug utilization review, prescribing errors, and clinical
outcomes. Journal of the American Medical Association 2003;
290:1494-1499.
Hennessy S, Bilker WB, Weber A, Strom BL. Descriptive analyses of the
integrity of a US Medicaid claims database. Pharmacoepidemiology and Drug
Safety 2003; 12:103-111.
Lautenbach E, Larosa LA, Kasbekar N, Peng HP, Maniglia
RJ, Fishman NO. Fluoroquinolone utilization in the emergency departments
of academic medical centers: prevalence of, and risk factors for, inappropriate
use. Archives of Internal Medicine 2003; 163:601-605.
M’ikanatha NM, Lautenbach E, Kunselman AR, Julian KG, Southwell BG,
Allswede M, Rankin JT, Aber RC. Sources of bioterrorism information among
emergency physicians during the 2001 anthrax outbreak. Biosecurity and
Bioterrorism: Biodefense Strategy, Practice, and Science 2003; 1(4):259-265.
Lautenbach E, Larosa LA, Marr AM, Nachamkin I, Bilker WB, Fishman NO.
Changes in the prevalence of vancomycin-resistant enterococci in response to
antimicrobial formulary interventions: impact of progressive restrictions on
use of vancomycin and third generation cephalosporins. Clinical Infectious
Diseases 2003; 36:440-446. W:\CERTpublications.html
Hagen EA, Lautenbach E, Olthoff K, Blumberg EA. Low prevalence of
colonization with vancomycin-resistant Enterococcus in patients awaiting liver
transplantation. American Journal of Transplantation 2003 Jul; 3(7):902-905.
M'ikanatha N, Southwell B, Lautenbach E. Automated laboratory reporting
of infectious diseases in a climate of bioterrorism. Emerging Infectious
Diseases 2003; 9:1053-1057.
Levy RM, Huang EY, Roling D,
Prins C, Kerdel FA, Padilla RS, Hunziker T, Chimenti S, Viard I, Mauri DN, Flynn K, Trent J, Margolis DJ, Saurat JH, and French LE, for the TEN-IVIG Study Group. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulin: Multicentre retrospective analysis of 48 consecutive cases. Archives of Dermatology 2003; 139: 26-32.
McGovern PC, Lautenbach E, Brennan PJ, Lustig RA, Fishman NO. Risk factors for postcraniotomy surgical site infection after 1,3-bis (2-chloroethyl)-1-nitrosourea (Gliadel) wafer placement. Clinical Infectious Diseases 2003; 36:759-765.
Metlay
JP, Strom BL, Asch DA. Prior antimicrobial drug exposure: a risk factor for
trimethoprim–sulfamethoxazole-resistant urinary tract infections. Journal of Antimicrobial Chemotherapy
2003; 51:963-970.
Metlay JP, Hardy C, Strom BL. Agreement between patient self-report and
a Veterans Affairs national database for identifying recent exposures to
antibiotics. Pharmacoepidemiology and Drug Safety 2003; 12:9-15.
Metlay JP, Fine MJ. Testing strategies in the initial management of
patients with community-acquired pneumonia. Annals of Internal Medicine
2003; 138(2):109-118.
Strom BL, Schinnar R, Apter A, Margolis
D, Lautenbach E, Hennessy S, Bilker W. Absence of cross-reactivity between
sulfonamide antibiotics and sulfonamide nonantibiotics.
2002
Bisson GP, Fishman NO, Patel JB, Edelstein PH, Lautenbach E.
Extended-spectrum ß-lactamase (ESBL)-producing Escherichia coli and Klebsiella
species (ESBL-EK): risk factors for colonization and impact of antimicrobial
formulary interventions on colonization prevalence. Infection Control and
Hospital Epidemiology 2002; 23(5):254-260.
Gross R, Bilker WB, Friedman HM, Coyne JC, Strom BL. Provider inaccuracy
in assessing adherence and outcomes with newly initiated antiretroviral therapy.
AIDS 2002 Sept 6; 16(13):1835-1837.
Hennessy S, Bilker WB, Knauss JS, Margolis DJ, Kimmel SE, Reynolds RF, Glasser DB, Morrison MF, Strom BL. Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. British Medical Journal 2002; 325:1070-1072.
Lautenbach E, Fishman NO, Bilker WB, Castiglioni A, Metlay JP, Edelstein
PH, Strom BL. Risk factors for fluoroquinolone resistance in nosocomial
Escherichia coli and Klebsiella pneumoniae infections. Archives of Internal
Medicine 2002; 162:2469-2477.
Lewis JD, Bilker WB, Brensinger C, Farrar JT, Strom BL. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications. American Journal of Gastroenterology 2002; 97(10):2540-2549.
Margolis DJ, Knauss J, Bilker W. Does hormone replacement therapy prevent pressure ulcers or venous leg ulcers? The Lancet 2002; 359: 675-7.
Metlay
JP, Shea JA, CrossW:\CERTpublications.htmlette LB, Asch DA. Tensions in
antibiotic prescribing: pitting social concerns against the interests of
individual patients. Journal of General Internal Medicine 2002;
17:87-94.
Metlay JP, Shea JA, Asch DA. Antibiotic prescribing decisions of
generalists and infectious disease specialists: thresholds for adopting new
drug therapies. Medical Decision Making 2002; 22:498-505.
Metlay JP. Update on community-acquired pneumonia: impact of antibiotic
resistance on clinical outcomes. Current Opinion in Infectious Diseases
2002; 15(2):163-167.
Metlay JP, Singer DE. Outcomes in lower respiratory tract infections and
the impact of antimicrobial drug resistance. Clinical Microbiology and
Infection 2002; 8 Suppl 2:1-11.
Joellenbeck LM, Zwanziger LL, Durch JS, Strom BL (eds). The anthrax
vaccine: is it safe? Does it work?
2001
Alessandrini EA, Shaw KN, Bilker WB, Schwartz DF,
Alessandrini EA, Shaw KN, Bilker WB, Perry K, Baker MD, Schwartz DF.
Effects of Medicaid managed care on health care use: infant emergency
department and ambulatory services. Pediatrics 2001; 108(1):103-110.
Gross R, Bilker WB, Friedman HM, Strom BL. Effect of adherence to newly
initiated antiretroviral therapy on plasma viral load. AIDS 2001;
15:2109-2117.
Gross R, Morgan AS, Kinky DE, Weiner M,
Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO.
Epidemiologic investigation of fluoroquinolone resistance in infections due to
extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella
pneumoniae. Clinical Infectious Diseases 2001; 33(8):1288-1294.
Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO.
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella
pneumoniae: risk factors for infection and impact of resistance on outcomes. Clinical
Infectious Diseases 2001; 32(8):1162-1171.
Margolis DJ, Kantor J, Santanna J,
Kantor J, Margolis DJ. Treatment options for diabetic neuropathic foot ulcers: a cost-effective analysis. DermatologicSsurgery 2001; 27:347-351.
Strom BL. Data validity issues in using claims data. Pharmacoepidemiology and Drug Safety 2001; 10: 389-392.
2000
Papasavvas E, Ortiz GM, Gross R, Sun J, Moore EC, Heymann JJ, Moonis M,
Sandberg JK, Drohan LA, Gallagher B, Shull J, Nixon DF, Kostman JR, Montaner
LJ. Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T
cell responses in chronically infected persons after temporary treatment
interruption. Journal of Infectious Diseases 2000; 182(3):766-775.
Margolis DJ, Crombleholme T, Herlyn M. Clinical protocol: phase I trial to evaluate the safety of H5.020CMV.PDGF-b for the treatment of a diabetic insensate foot ulcer. Wound Repair and Regeneration 2000; 8: 480-493.
Abstracts, Letters, Editorials, Commentaries,
Books, Book Chapters, Issue Briefs:
2006
Apter AJ, Strom BL. Reacting to antibiotic allergies. LDI Issue Brief 2006: 11 (7): 1-4.
Gross R, Bilker WB, Chapman J, Coyne JC, Friedman HM,Strom BL. High level, but not low level HIV breakthrough on Efavirenz-based regimens associated with poor adherence. Pharmacoepidemiology and Drug Safety 2006; 15: S69-70.
Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiology and Drug Safety 2006; 15: S233-234.
Lo Re V, Kostman J, Gross R, Reddy R, Putt M, Frank I, Strom B. Incidence and risk factors for weight loss during dual HIV/Hepatitis C Virus Therapy. Pharmacoepidemiology and Drug Safety 2006; 15: S68.
Margolis,
DJ. Antibiotics, Acne, and Upper Respiratory Tract Infections. LDI Issue
Brief February 2006; 2(4):1-4.
Margolis DJ. Antibiotic use in acne associated with respiratory tract infection. “Spotlight on Research" section of the NIAMS Web site (http://www.niams.nih.gov/ne/index.htm). http://www.niams.nih.gov/ne/highlights/spotlight/2006/acne_infection.htm
Meropol SB, Glick HA, Asch DA. Alternative strategies for diagnosis and treatment of pediatric acute Otitis Media. Pharmacoepidemiology and Drug Safety 2006; 15: S299.
M'ikanatha N. How elephants can promote appropriate antibiotics use. (Book Review) Archives of Pediatrics and Adolescent Medicine. http://archpedi.ama-assn.org/cgi/content/short/160/8/860; August 2006, p. 860.
2005
Halpern
SD,
Hass DJ, Lewis JD. Quality of data provided to physicians by dietary
supplement manufacturers in support of safety and efficacy claims. Pharmacoepidemiology
and Drug Safety 2005; 14:S9.
Metlay, JP, Kinman JL, Crossette L. Physician attitudes and practice
patterns concerning outpatient antibiotic use for older adults. Pharmacoepidemiology
and Drug Safety 2005; 14:S88-89.
Committee on Smallpox Vaccination Program
Implementation, Board on Health Promotion and Disease Prevention; Baciu A,
Anason AP, Stratton K, Strom B
(eds). The Smallpox Vaccination Program:
Public Health in an Age of Terrorism.
2004
Apter AJ, Kinman JL, Bilker WB, Herlim M, Margolis DJ, Lautenbach E,
Hennessy S, Strom BL. Re-prescription of penicillin in patients who have had
allergic-like reactions: investigation using a large electronic medical record.
Journal of Allergy and Clinical Immunology 2004; 113:S67.
Apter AJ, Kinman JL, Bilker WB, Herlim M, Margolis DJ, Lautenbach E,
Hennessy S, Strom BL. Is there cross-reactivity between penicillins and
cephalosporins? Investigation using a large electronic medical record database.
Pharmacoepidemiology and Drug Safety 2004; 13:S18. (Abstract No. 035)
Dine CJ,
Kimmel
SE, Berlin JA, Reilly M, Jaskowiak J, Kishel L, Chittams J, Strom BL. The effects of nonselective
non-aspirin nonsteroidal anti-inflammatory medications on the risk of nonfatal
myocardial infarction and their interaction with aspirin. Journal of the
Lautenbach E. Epidemiological methods in infection control. Chapter 5
In: Lautenbach E, Woeltje K, eds. Practical handbook for healthcare
epidemiologists. 2nd ed.
Lautenbach E, Woeltje K. Practical handbook for healthcare
epidemiologists. 2nd ed. Official publication of the Society for Healthcare
Epidemiology of America (SHEA),
Gould C, Lautenbach E. Meningitis
and encephalitis. In: Loeb M, Smaill F, Smieja M, editors, Evidence-based
infectious diseases.
Lewis JD, Bilker WB, Weinstein RB, Strom BL. Measuring incidence rates using GPRD: how soon after registration do incidence rates reach baseline levels? (Abstract #459). Pharmacoepidemiology and Drug Safety 2004; 13: S230.
Lewis JD, Localio AR, Kimmel SE, Farrar JT, Metz DC, Nessel LC, Brensinger C, Strom BL. Frequency of use influences recall of NSAID exposure (Abstract #5). Pharmacoepidemiol Drug Safety 2004; 13: S3.
Kimmel
SE,
Linkin DR, Brennan PJ. Infection control and patient safety. Chapter 25. In: Lautenbach E, Woeltje K. (Ed). A Practical Handbook for Healthcare Epidemiologists (2nd
edition).
Finch RG, Metlay JP, Davey PG, Baker LJ. Educational interventions to
improve antibiotic use in the community: report from the International Forum on
Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infectious Diseases
2004; 4(1):44-53.
Strom BL. Potential for conflict of interest in the evaluation of
suspected adverse drug reactions: a counterpoint. Journal of the American
Medical Association 2004; 292 (21):2643-2646. (Commentary)
2003
Apter AJ, Kinman J, Bilker WB, Herlim M, Sallen A, Strom BL. Incidence
of events consistent with hypersensitivity reactions to penicillin in a large
electronic medical record database. Journal of Allergy and Clinical
Immunology 2003; 111(2):S257.
Sauer WH,
Zaoutis
TE, Everett WW, Halpern SD, Strom BL, Kim J, Coffin SE. Pre-event
vaccination against smallpox: a survey of pediatric emergency health care
providers. Pediatric Research 2003; 53:455A. (Abstract No. 573).
Zaoutis T, Greves M, Lautenbach E, Coffin S. Risk factors for
disseminated candidiasis in children with candidemia. In: Program and Abstracts
of the 13th Annual Meeting of the Society for Healthcare
Epidemiology of
Everett WW, Strom BL. Smallpox vaccination: from policy to
implementation. Pharmacoepidemiology and Drug Safety 2003; 12 (Suppl
1):S187-S188 (Abstract No. 372).
Everett WW, Coffin SE, Zaoutis T,
Farrar JT, Mikuls TR, Saag KG, Bilker W, Fernandes S, Strom BL. Issues
in the determination of disease prevalence from medical record databases:
cumulative incidence in chronic diseases such as gout. Pharmacoepidemiology
and Drug Safety 2003; 12:S172.
Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG. The treatment of
asymptomatic hyperuricemia: results from the population-based General Practice
Research Database (GPRD). Pharmacoepidemiology and Drug Safety 2003;
12:S116.
Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG. Gout epidemiology
and pharmacoepidemiology: results from the General Practice Research Database
(GPRD). Pharmacoepidemiology and Drug Safety 2003; 12:S116.
Gross R, Strom BL. Toward Improved adverse event/suspected adverse drug reaction reporting. Pharmacoepidemiology and Drug Safety March 2003; 12(2):89-91. (Editorial)
Gross R, Bilker W, Hennessy S, Farrar J, Strom B. Accuracy of days supply
vs. pills dispensed in Medicaid data. Pharmacoepidemiology and Drug Safety
2003; 12:S161.
Hennessy S, Strom BL. The ineffectiveness of retrospective drug
utilization review. LDI Issue Brief 2003; 9(1):1-4.
Lautenbach E, Strom BL, Nachamkin I, Bilker WB, Marr AM, Larosa LA,
Fishman NO. Fluoroquinolone resistance in Enterobacteriaceae: significant
differences in longitudinal trends across organisms and inpatient and
outpatient settings. In: Program and Abstracts of the 13th Annual Meeting of
the Society for Healthcare Epidemiology of
Marr AM, LaRosa LA, Lautenbach E,
VanBerkom DL, Fishman NO. Evaluation of the appropriate use of
vancomycin for surgical would prophylaxis. In: Program and Abstracts of the 13th
Annual Meeting of the Society for Healthcare Epidemiology of
Marr AM, LaRosa LA, Lautenbach
E, VanBerkom DL, Fishman NO. Evaluation of the appropriate use of
vancomycin for empiric or directed therapy according to antimicrobial
management program guidelines. In: Program and Abstracts of the 13th
Annual Meeting of the Society for Healthcare Epidemiology of
Aberra FN, Brensinger CM, Bilker WB, Strom BL, Lichtenstein GR, Lewis JD.
Antibiotic use and the risk for flares of inflammatory bowel disease. Pharmacoepidemiology
and Drug Safety 2003; 12:S125.
Linkin DL, Fishman NO. Ciprofloxacin versus tobramycin for neutropenic
fevers. Annals of Internal Medicine 2003; 138 (5):435-436. (Letter)
Linkin DR, Paris S, Fishman NO, Metlay JP, Lautenbach E. The epidemiology
of inaccurate communications during antimicrobial management interactions. Pharmacoepidemiology
and Drug Safety 2003; 12:S88.
Linkin DR, Paris S, Fishman NO, Metlay JP, Lautenbach E. Communication
errors during antimicrobial management telephone interactions. In: Program and
Abstracts of the 13th Annual Meeting of the Society for Healthcare
Epidemiology of
M'ikanatha N, Welliver D, Rohn D, Rankin J, Lautenbach E. Impact of the
web on enhancing infectious disease reporting and bioterrorism preparedness:
current capabilities and future promise. In: Program and Abstracts of the 13th
Annual Meeting of the Society for Healthcare Epidemiology of
M'ikanatha NM, Lautenbach E, Kunselman AR, Southwell B, Allswede M,
Rankin JT, Aber R. Public health preparedness and antimicrobial utilization among
emergency department physicians during the 2001 bioterrorism anthrax outbreak.
In: Program and Abstracts of the 13th Annual Meeting of the Society for
Healthcare Epidemiology of
Metlay JP, Kinman JL. Failure to validate pneumococcal pneumonia
diagnoses in the General Practice Research Database. Pharmacoepidemiology
and Drug Safety 2003; 12:S163-164.
Strom BL. Committee on Smallpox Vaccination Program Implementation.
Institute of Medicine 2003; http://www.iom.edu/IOM/IOMHome.nsf/Pages/Smallpox+Vaccination
Strom
BL. Introduction to the FDA Drug Safety and Risk Management Advisory
Committee. Pharmacoepidemiology and Drug Safety 2003; 12:S150.
Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy S, Bilker WB, Pettitt D. Lack of specific cross-reactivity between sulfonamide antibiotics and subsequent sulfonamide non-antibiotics. Pharmacoepidemiology and Drug Safety 2003; 12:S123.
Strom BL. Introduction to the FDA drug safety and risk management advisory committee. Pharmacoepidemiology and Drug Safety 2003; 12:S150.
Kimmel SE,
Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy S, Bilker WB, Pettitt D. Lack of specific cross-reactivity between sulfonamide antibiotics and subsequent sulfonamide non-antibiotics. Pharmacoepidemiology and Drug Safety 2003; 12:S123.
2002
Berlin J, Santanna J, Schmid C, Szczech M, Feldman H. Anti-lymphocyte antibody induction therapy study group. Individual patient versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Statistics in Medicine 2002; 21(3):371-387.
Gross R. Adherence in HIV Drug therapy. LDI Issue Brief 2002;
8(3):1-4.
Lautenbach E, Fishman NO, Metlay JP, Bilker WB, Edelstein PH, Strom BL.
Fluoroquinolone (FQ) resistance is independently associated with increased
mortality in nosocomial Escherichia coli (EC) and Klebsiella pneumoniae (KP)
infections. In: Program and Abstracts of the 12th Annual Meeting of
the Society for Healthcare Epidemiology of America (SHEA), Salt Lake City,
Utah, April 2002.
Lautenbach E, Gould CV, Larosa LA, Marr AM, Nachamkin I, Bilker WB,
Fishman NO. Emergence and epidemiology of resistance to Chloramphenicol (C)
among Vancomycin-Resistant Enterococcal (VRE) bloodstream isolates. In: Program
and Abstracts of the 12th Annual Meeting of the Society for Healthcare Epidemiology
of America (SHEA), Salt Lake City, Utah, April 2002.
Metlay JP. Tensions in antibiotic prescribing. LDI Issue Brief
2002; 7(7):1-4.
Moellering RC, Craig W, Edmond M, Farrell DJ, Ferraro MJ, File TM, Klein J,
Lonks J, Metlay JP, Sahm D, Talbot GH. Clinical and public health
implications of macrolide-resistant Streptococcus pneumoniae. Journal of
Chemotherapy 2002; 14(S3):42-56.
2001
Gross R. Proactive Surveillance Symposium: the direction and
needs of drug safety in the 21st century. Pharmacoepidemiology
and Drug Safety 2001; 10:189.
Editorial
Hennessy
S, Strom BL. Statins and
fracture risk [editorial]. Journal of the American Medical Association
2001; 285:1888-1889.
Metlay
JP, Shea JA, Asch DA. How do physicians balance individual and social
concerns in their use of antibiotics? Journal of General Internal Medicine.
2001; 16(S1):209.
Strom BL. When data conflict with practice: rethinking the use of
prophylactic antibiotics before dental treatment. LDI Issue Brief
March 2001; 2(6):1-4.
2000
Metlay JP, Strom BL, Asch DA . Antimicrobial drug risk factors for drug
resistant urinary tract infections. Clinical Infectious Diseases 2000;
31:213.
Last Update January 2007
PennCERT publications
|
|
